127 related articles for article (PubMed ID: 16545401)
1. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
2. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
3. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
5. Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits.
Steiner D; Saya D; Schallmach E; Simonds WF; Vogel Z
Cell Signal; 2006 Jan; 18(1):62-8. PubMed ID: 15925485
[TBL] [Abstract][Full Text] [Related]
6. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
8. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
9. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
10. Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.
Varga EV; Rubenzik MK; Stropova D; Sugiyama M; Grife V; Hruby VJ; Rice KC; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 2003 Jul; 306(1):109-15. PubMed ID: 12660310
[TBL] [Abstract][Full Text] [Related]
11. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
Wang H; Guang W; Barbier E; Shapiro P; Wang JB
Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
[TBL] [Abstract][Full Text] [Related]
12. Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein.
Wang HY; Burns LH
J Neurobiol; 2006 Oct; 66(12):1302-10. PubMed ID: 16967511
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
14. Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires Gs but is not mediated by the Gsalpha subunit.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1998 Aug; 286(2):855-62. PubMed ID: 9694942
[TBL] [Abstract][Full Text] [Related]
15. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
16. Chronic morphine acts via a protein kinase Cgamma-G(beta)-adenylyl cyclase complex to augment phosphorylation of G(beta) and G(betagamma) stimulatory adenylyl cyclase signaling.
Chakrabarti S; Regec A; Gintzler AR
Brain Res Mol Brain Res; 2005 Jul; 138(1):94-103. PubMed ID: 15908039
[TBL] [Abstract][Full Text] [Related]
17. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor.
Zarnegar P; Persson AI; Ming Y; Terenius L
Neurosci Lett; 2006 Apr; 396(3):197-201. PubMed ID: 16377088
[TBL] [Abstract][Full Text] [Related]
18. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization.
Zhao H; Loh HH; Law PY
Mol Pharmacol; 2006 Apr; 69(4):1421-32. PubMed ID: 16415176
[TBL] [Abstract][Full Text] [Related]
19. Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance.
Chakrabarti S; Rivera M; Yan SZ; Tang WJ; Gintzler AR
Mol Pharmacol; 1998 Oct; 54(4):655-62. PubMed ID: 9765508
[TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase C in ethanol-induced activation of adenylyl cyclase.
Rabbani M; Nelson EJ; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 1999 Jan; 23(1):77-86. PubMed ID: 10029206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]